The Melanoma Epidemic: Res Ipsa Loquitur
- 1 October 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 8 (5) , 459-465
- https://doi.org/10.1634/theoncologist.8-5-459
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the factors suggesting the melanoma epidemic is real and not artificial. List the major risk factors for melanoma and preventative measures. Describe the relationships between age and gender and melanoma risk. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at CME.TheOncologist.com Many have debated whether or not we are in the midst of a melanoma epidemic. Some facts are clear and helpful to this debate, while others are less clear. The incidence and mortality of melanoma have increased over the last several decades, but the incidence has risen faster than the mortality. The incidence has risen 3%–7% on average over several decades and even more rapidly among Caucasian men and the elderly. In the U.S., the incidence in men is higher than in women after the age of 40, and the difference between men and women increases from age 40 until the end of life. The incidence in the U.S. has risen most rapidly among in situ and localized lesions, but distant and regional disease have increased as well. Among localized disease, in the U.S. from 1988–1997, all stages increased by comparable amounts. This strongly argues against the idea that the increase in incidence of melanoma is only due to early detection of thin lesions or biologically benign lesions, at least during the time period studied. On the other hand, early detection of thin lesions may well account for lower increases in mortality than incidence and improvements in survival. Survival has increased from approximately 60% in the 1960s to 89% in recent years. Improvements in survival appear to be related to earlier diagnosis, rather than an improvement in survival of a given stage. Studies consistently point to a major role for UV light exposure as the most important risk factor for those individuals with a phenotypic susceptibility. Public health efforts aim at primary and secondary prevention strategies. Primary prevention strategies attempt to prevent people from developing melanoma, primarily through avoiding exposure to UV light. There is a particular emphasis on avoidance of UV light exposure in childhood and young adulthood, when it appears the risk is greatest. When strict avoidance cannot be adhered to, sunscreens have been logically recommended. Secondary prevention strategies include screening campaigns and educational campaigns. Many of these strategies appear promising but require further rigorous testing. The melanoma epidemic has arisen for a variety of reasons including: a true increase in melanomas of malignant behavior, a particularly high increase in localized and in situ lesions, and an increase in the number of biopsies performed, which may have resulted in an increased detection of less aggressive lesions. The contribution of possible changes in the diagnostic criteria for melanoma to the increased incidence remains unknown.Keywords
This publication has 35 references indexed in Scilit:
- Precursors to melanoma and their mimics: nevi of special sitesLaboratory Investigation, 2006
- Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for managementJournal of the American Academy of Dermatology, 1995
- An analysis of a melanoma epidemicInternational Journal of Cancer, 1993
- Who discovers melanoma?: Patterns from a population-based surveyJournal of the American Academy of Dermatology, 1992
- Audit of public education campaign to encourage earlier detection of malignant melanoma.BMJ, 1992
- Melanoma and sun exposure: Contrasts between intermittent and chronic exposureWorld Journal of Surgery, 1992
- Who is being screened for melanoma/skin cancer?: Characteristics of persons screened in MassachusettsJournal of the American Academy of Dermatology, 1991
- THE RELATIONSHIP BETWEEN MALIGNANT MELANOMA OF SKIN AND EXPOSURE TO SUNLIGHTPhotochemistry and Photobiology, 1989
- Number of melanocytic nevi as a major risk factor for malignant melanomaJournal of the American Academy of Dermatology, 1987
- The pathogenesis of cutaneous malignant melanoma.BMJ, 1983